Does PAZOPANIB Cause Ejection fraction decreased? 72 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 72 reports of Ejection fraction decreased have been filed in association with PAZOPANIB (Pazopanib). This represents 0.3% of all adverse event reports for PAZOPANIB.
72
Reports of Ejection fraction decreased with PAZOPANIB
0.3%
of all PAZOPANIB reports
10
Deaths
31
Hospitalizations
How Dangerous Is Ejection fraction decreased From PAZOPANIB?
Of the 72 reports, 10 (13.9%) resulted in death, 31 (43.1%) required hospitalization, and 6 (8.3%) were considered life-threatening.
Is Ejection fraction decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PAZOPANIB. However, 72 reports have been filed with the FAERS database.
What Other Side Effects Does PAZOPANIB Cause?
Death (3,767)
Diarrhoea (2,907)
Fatigue (1,883)
Nausea (1,879)
Malignant neoplasm progression (1,471)
Drug ineffective (1,135)
Decreased appetite (1,116)
Vomiting (1,072)
Hypertension (1,004)
Malaise (764)
What Other Drugs Cause Ejection fraction decreased?
SACUBITRIL\VALSARTAN (2,551)
TRASTUZUMAB (1,579)
DOXORUBICIN (834)
CYCLOPHOSPHAMIDE (754)
PERTUZUMAB (644)
DOCETAXEL (520)
PACLITAXEL (466)
BISOPROLOL (314)
RITUXIMAB (296)
CARVEDILOL (284)
Which PAZOPANIB Alternatives Have Lower Ejection fraction decreased Risk?
PAZOPANIB vs PEANUT
PAZOPANIB vs PEG INTERFERON
PAZOPANIB vs PEG-INTERFERON ALFA 2A
PAZOPANIB vs PEGASPARGASE
PAZOPANIB vs PEGASYS